Enveric Biosciences ENVB
NASDAQ ENVB
$1.46 -0.01 (-0.68%)
As of: Sep 29, 2026 · 3:58 PM EDT

Enveric Biosciences (ENVB) Current Debt (2019 - 2020)

Updated

Enveric Biosciences (ENVB) reported Current Debt of $3.17 million for Q1 2020, compared with -$19,772 a year earlier.

Analysis

Enveric Biosciences (ENVB) Current Debt (2019 - 2020) Analysis & Trends

For FY2019, Enveric Biosciences posted Current Debt of -$1.33 million.

  • By year, Current Debt came in at -$1.98 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Enveric Biosciences 5.86 Mn -15.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 3.17 Mn
Mar 31, 2019 -19,772.00
API Access

Enveric Biosciences Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ENVB&period=max&api_key=YOUR_API_KEY